Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome

AIMS: Angiotensin receptor-neprilysin inhibitor (ARNI) is an established treatment for heart failure. However, whether ARNI has renoprotective effects beyond renin-angiotensin system inhibitors alone in cardiorenal syndrome (CRS) has not been fully elucidated. Here, we examined the effects of ARNI o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Shunichiro, Wakui, Hiromichi, Uehara, Tatsuki, Shiba, Yuka, Azushima, Kengo, Abe, Eriko, Tanaka, Shohei, Taguchi, Shinya, Hirota, Keigo, Urate, Shingo, Suzuki, Toru, Yamada, Takayuki, Kinguchi, Sho, Yamashita, Akio, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630100/
https://www.ncbi.nlm.nih.gov/pubmed/37941728
http://dx.doi.org/10.1093/ehjopen/oead098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630100/
https://www.ncbi.nlm.nih.gov/pubmed/37941728
http://dx.doi.org/10.1093/ehjopen/oead098

Ejemplares similares